SCHEMBL6186385

SCHEMBL6186385

O=C1C=CC(=O)c2cnccc21

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOA P21397 2/20 0.52
▸ MAOB P27338 2/20 0.52
▸ CDC25B P30305 3/20 0.50
▸ IDO1 P14902 2/20 0.48
▸ AKT1 P31749 1/20 0.48
▸ SNCA P37840 1/20 0.48
▸ MAP2K1 Q02750 1/20 0.48
▸ PIN1 Q13526 1/20 0.48
▸ EHMT2 Q96KQ7 1/20 0.48
▸ NSD1 Q96L73 1/20 0.48
▸ EHMT1 Q9H9B1 1/20 0.48
▸ SMN1; SMN2 Q16637 5/20 0.43
▸ MAPT P10636 4/20 0.43
▸ BLM P54132 4/20 0.43
▸ TP53 P04637 3/20 0.43
▸ CYP3A4 P08684 3/20 0.43
▸ CASP1 P29466 3/20 0.43
▸ CASP7 P55210 2/20 0.43
▸ S100A4 P26447 2/20 0.40
▸ TSHR P16473 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21332894 0.81 MAOA (0.43) MAOAMAOBCDC25BIDO1AKT1
SCHEMBL30616365 0.74 MAOA (0.86) MAOAMAOBCDC25BIDO1SMN1; SMN2
SCHEMBL20618218 0.74 MAOA (0.77) MAOAMAOBCDC25BSMN1; SMN2MAPT
SCHEMBL8417659 0.74 MAOA (0.86) MAOAMAOBCDC25BIDO1SMN1; SMN2
SCHEMBL9269089 0.74 MAOA (0.77) MAOAMAOBCDC25BIDO1SMN1; SMN2
SCHEMBL31112247 0.74 MAOA (0.77) MAOAMAOBCDC25BSMN1; SMN2MAPT
SCHEMBL30956639 0.74 MAOA (0.70) MAOAMAOBCDC25BIDO1SMN1; SMN2
SCHEMBL16685145 0.74 MAOA (0.70) MAOAMAOBCDC25BSMN1; SMN2MAPT
SCHEMBL15855938 0.70 MAPT (0.57) MAOAMAOBCDC25BIDO1SNCA
SCHEMBL16879448 0.70 MAOA (0.52) MAOAMAOBCDC25BSMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115028626-A Thermally induced delayed fluorescent material and preparation method and application thereof 西北工业大学 2022-09-09 — — CN claimed
US-9096519-B2 Process for the synthesis of ketones from internal alkenes CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2015-08-04 — — US claimed
US-20140194604-A1 PROCESS FOR THE SYNTHESIS OF KETONES FROM INTERNAL ALKENES CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2014-07-10 — — US claimed
EP-0107364-A2 7-Anilinoisoquinoline-5,8-quinones ELI LILLY AND COMPANY (US) 1984-05-02 — — EP claimed
WO-2025152949-A1 ISOQUINOLINE-5,8-DIONE DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF 浙江大学 2025-07-24 — — WO disclosed
WO-2025152949-A1 ISOQUINOLINE-5,8-DIONE DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF 浙江大学 2025-07-24 — — WO disclosed
CN-120329252-A Isoquinoline-5, 8-dione derivative and preparation method and application thereof 浙江大学 2025-07-18 — — CN disclosed
CN-120329252-A Isoquinoline-5, 8-dione derivative and preparation method and application thereof 浙江大学 2025-07-18 — — CN disclosed
EP-3934634-B1 SUBSTITUTED BICYCLIC AND TETRACYCLIC QUINONES AND RELATED METHODS OF USE UNIV MICHIGAN REGENTS (US) 2024-07-24 — — EP disclosed
CN-115028626-B Thermally-induced delayed fluorescent material and preparation method and application thereof 西北工业大学 2023-10-17 — — CN disclosed
CN-114422400-B Method and apparatus for real-time traffic steering using real-time user monitoring data 动态网络服务股份有限公司 2023-09-05 — — CN disclosed
CN-115028626-A Thermally induced delayed fluorescent material and preparation method and application thereof 西北工业大学 2022-09-09 — — CN disclosed
EP-0374182-A1 BIOSPECIFIC POLYMERS. KANEGAFUCHI CHEMICAL IND (JP) 1990-06-27 — — EP disclosed
EP-0161102-B1 ISOQUINOLINE DERIVATIVES GLAXO GROUP LIMITED (GB) 1990-02-21 — — EP disclosed
US-4835158-A Isoquinoline derivatives GLAXO GROUP LIMITED (GB) 1989-05-30 — — US disclosed
WO-1989001335-A1 BIOSPECIFIC POLYMERS KANEGAFUCHI CHEMICAL INDUSTRY CO., LTD. (JP) 1989-02-23 — — WO disclosed
US-4737544-A METHYL ACRYLAMIDOGLYCOLATE METHYL ETHER, HYDROXYETHYL METHACRYLATE, AND METHYL METHACRYLATE TERPOLYMER SUPPORT WITH IMMOBILIZED BIOLOGICALS BIOSPECIFIC TECHNOLOGIES, INC. (US) 1988-04-12 — — US disclosed
EP-0161102-A2 Isoquinoline derivatives GLAXO GROUP LIMITED (GB) 1985-11-13 — — EP disclosed
US-4478820-A Anilino-substituted isoquinoline quinones, pharmaceutical compositions and method of use thereof ELI LILLY AND COMPANY (US) 1984-10-23 — — US disclosed
EP-0107364-A2 7-Anilinoisoquinoline-5,8-quinones ELI LILLY AND COMPANY (US) 1984-05-02 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140194604-A1 PROCESS FOR THE SYNTHESIS OF KETONES FROM INTERNAL ALKENES FASN, NOTUM, DGAT2 MAOA 265/4885MAOB 184/4885CDC25B 2960/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback